Trial drug for treatment of fatigue in MS. Don't know what their other MS drugs are or what phase they are in.
MultiCell to Present Company's Portfolio of Novel Drug Candidates at BIO 2006 Conference; Company President Dr. Stephen Chang to Discuss Novel Therapeutic Candidates Targeting Multiple Sclerosis, Diabetes and Other Medical Needs
SAN DIEGO--(BUSINESS WIRE)--April 10, 2006 - MultiCell Technologies, Inc. (OTCBB:MCET), developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and ...
Read more : MCT-125
| Views :
1478 | Replies :